Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.071 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.078 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |